文献速递心力衰竭与心肌病心律失常瓣膜病与结构性心脏病

原发性心肌纤维化可作为遗传性心脏结构疾病的替代表型途径

Primary Myocardial Fibrosis as an Alternative Phenotype Pathway of Inherited Cardiac Structural Disorders.
PubMed 文献 · Circulation · 2018-01-01

该研究在芬兰北部4031例连续心源性猝死尸检者中,对145例仅见原发性心肌纤维化(PMF)者行174个基因的靶向二代测序;96例DNA合格样本中26例(27%)检出已知或意义不明变异,10例(10%)为致病/可能致病变异,主要涉及致心律失常性右室心肌病、肥厚型心肌病和扩张型心肌病相关基因,提示PMF可为结构疾病相关遗传变异的替代表型。

要点

  • PMF尸检者中27%检出心肌结构相关基因变异,10%为致病/可能致病变异。
  • 变异主要分布于ARVC、HCM和DCM相关基因,未检出离子通道基因致病变异。
  • PMF可能是遗传性结构性心脏病的一种替代表型,对尸检基因检测和家系风险评估有临床意义。

核心结论

  • 较大比例PMF尸检者携带ARVC、DCM和HCM相关基因变异,而无相应疾病尸检发现。
  • PMF可能是结构性心脏病相关遗传变异的替代表型表达,或风险相关纤维化先于原发疾病出现。
  • 该发现对尸检基因检测和家系风险分层具有临床意义。

研究设计与样本

  • 研究纳入芬兰北部4031例连续心源性猝死尸检者,其中145例以PMF为唯一结构发现。
  • 对无继发性心肌纤维化病因者,用174个心肌结构和离子通道功能相关基因行靶向二代测序。
  • 96例(66%)标本DNA通过质控,按ACMG共识指南对蛋白效应变异且次要等位基因频率<0.01者进行分类。

主要发现

  • 96例中26例(27%)检出已知或意义不明变异:10例(10%)为致病/可能致病变异,16例(17%)为意义不明变异(涉及11个基因)。
  • 5个变异位于ARVC相关基因,6个位于HCM相关基因,11个位于DCM相关基因,2个与上述疾病无关。
  • 4个独特的意义不明变异在多个无亲缘关系的PMF受试者中共分离。
  • 离子通道编码基因中未检出致病/可能致病变异。

关键数值与推荐

  • 变异分类依据ACMG共识指南,纳入蛋白效应且次要等位基因频率<0.01的变异。

临床怎么用

  • 对尸检发现PMF者,可考虑行结构性心脏病相关基因检测以辅助家系风险评估。
  • PMF应被视为遗传性结构性心脏病可能的替代表型,而非孤立性非遗传性发现。

局限性

  • 仅66%(96/145)PMF标本DNA通过质控,可能影响变异检出代表性。
  • 意义不明变异比例较高,部分变异致病性尚未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myocardial fibrosis is a common postmortem finding among young individuals with sudden cardiac death. Because there is no known single cause, we tested the hypothesis that some cases of myocardial fibrosis in the absence of identifiable causes (primary myocardial fibrosis [PMF]) are associated with genetic variants. METHODS: Tissue was obtained at autopsy from 4031 consecutive individuals with sudden cardiac death in Northern Finland, among whom PMF was the only structural finding in 145 subjects with sudden cardiac death. We performed targeted next-generation sequencing using a panel of 174 genes associated with myocardial structure and ion channel function when autopsies did not identify a secondary basis for myocardial fibrosis. All variants with an effect on protein and with a minor allele frequency <0.01 were classified as pathogenic or variants of uncertain significance on the basis of American College of Medical Genetics consensus guidelines. RESULTS: Among the 96 specimens with DNA passing quality control (66%), postmortem genetic tests identified 24 variants of known or uncertain significance in 26 subjects (27%). Ten were pathogenic/likely pathogenic variants in 10 subjects (10%), and 14 were variants of uncertain significance in 11 genes among 16 subjects (17%). Five variants were in genes associated with arrhythmogenic right ventricular cardiomyopathy, 6 in hypertrophic cardiomyopathy-associated genes, and 11 in dilated cardiomyopathy-associated genes; 2 were not associated with these disorders. Four unique variants of uncertain significance cosegregated among multiple unrelated subjects with PMF. No pathogenic/likely pathogenic variants were detected in ion channel-encoding genes. CONCLUSIONS: A large proportion of subjects with PMF at autopsy had variants in genes associated with arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, and hypertrophic cardiomyopathy without autopsy findings of those diseases, suggesting that PMF can be an alternative phenotypic expression of structural disease-associated genetic variants or that risk-associated fibrosis was expressing before the primary disease. These findings have clinical implications for postmortem genetic testing and family risk profiling.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Junttila MJ, Holmström L, Pylkäs K, et al. Primary Myocardial Fibrosis as an Alternative Phenotype Pathway of Inherited Cardiac Structural Disorders. Circulation. 2018. PMID: 29915098. doi:10.1161/CIRCULATIONAHA.117.032175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。